Showing 2 posts of 2 posts found.
The FDA has granted priority review for Merck (MSD) and Eisai’s application for two new approvals for the combination of …
Researchers at The Institute of Cancer Research (ICR) in London have discovered a new use for an ovarian and breast …
AbbVie expands Oxford R&D facility with new £120m UK research commitment
MedPharm appoints Jason Mieding as chief operating officer
UKRI backs five hubs developing AI tools for earlier disease detection
Coriolis Pharma appoints Teun van der Heide as CEO
NEC joins €6.5m European project using AI for pandemic vaccine design